相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cannabis, Cannabinoids, and the Endocannabinoid SystemIs there Therapeutic Potential for Inflammatory Bowel Disease?
Tim Ambrose et al.
JOURNAL OF CROHNS & COLITIS (2019)
Genetic vulnerability to schizophrenia is associated with cannabis use patterns during adolescence
Marieke Hiemstra et al.
DRUG AND ALCOHOL DEPENDENCE (2018)
Cannabinoid pharmacology and therapy in gut disorders
J. A. Uranga et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Cannabis for the treatment of Crohn's disease
Tahir S. Kafil et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)
May cannabinoids prevent the development of chemotherapy-induced diarrhea and intestinal mucositis? Experimental study in the rat
R. Abalo et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2017)
Role of cannabis in digestive disorders
Hemant Goyal et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2017)
Cannabinoids as gastrointestinal anti-inflammatory drugs
A. Fabisiak et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2017)
Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
Carina Hasenoehrl et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2017)
Role of Cannabinoids in Gastrointestinal Mucosal Defense and Inflammation
Klara Gyires et al.
CURRENT NEUROPHARMACOLOGY (2016)
The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease
C. Hasenoehrl et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2016)
Cannabinoids for Medical Use A Systematic Review and Meta-analysis
Penny F. Whiting et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Endocannabinoid signaling at the periphery: 50 years after THC
Mauro Maccarrone et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract
Maciej Salaga et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Cannabis Use Provides Symptom Relief in Patients with Inflammatory Bowel Disease but Is Associated with Worse Disease Prognosis in Patients with Crohn's Disease
Martin Storr et al.
INFLAMMATORY BOWEL DISEASES (2014)
Marijuana Use Patterns Among Patients with Inflammatory Bowel Disease
Jessica Ravikoff Allegretti et al.
INFLAMMATORY BOWEL DISEASES (2013)
Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea
B. S. Wong et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2012)
The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings
A. Mallat et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Cannabis use amongst patients with inflammatory bowel disease
Simon Lal et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2011)
Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study
T. Esfandyari et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2006)
Dronabinol and marijuana in HIV plus marijuana smokers: acute effects on caloric intake and mood
M Haney et al.
PSYCHOPHARMACOLOGY (2005)
Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats
R Mathison et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Endocannabinoids as physiological regulators of colonic propulsion in mice
L Pinto et al.
GASTROENTEROLOGY (2002)
Localisation of cannabinoid CB1 receptor immunoreactivity in the guinea pig and rat myenteric plexus
AA Coutts et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2002)
分享论文
